Cannabinoid Receptor-2 Alleviates Sepsis-Induced Neuroinflammation by Modulating Microglia M1/M2 Subset Polarization Through Inhibiting Nogo-B Expression
- PMID: 40102346
- DOI: 10.1007/s12035-025-04836-2
Cannabinoid Receptor-2 Alleviates Sepsis-Induced Neuroinflammation by Modulating Microglia M1/M2 Subset Polarization Through Inhibiting Nogo-B Expression
Abstract
Few studies have investigated how Nogo-B affects sepsis-associated encephalopathy (SAE). Cannabinoid receptor 2 (CB2R) plays a critical role in regulating M1/M2 polarization in microglia. This study aimed to explore the association between CB2R and Nogo-B by assessing changes in microglial polarization markers.C57BL/6 mice with SAE induced by cecal ligation and puncture (CLP) surgery were intraperitoneally injected with HU308 for 3 consecutive days at the same time after that, and changes in cognitive function were assessed. After Lipopolysaccharides (LPS) and Interleukin-4 (IL-4) were used to induce BV2 microglial cell models respectively, HU308 and AM630 were applied to assess changes in inflammatory factors, microglial polarization markers, and the expression levels of CB2R and Nogo-B in microglial cells. We established a stable Nogo-B overexpression cell line. ELISA, Western blot, and flow cytometry were utilized to verify whether Nogo-B is a crucial protein in controlling BV2 cell polarization by HU308. There was an increase in Nogo-B protein expression during SAE. HU308 treatment alleviated the cognitive impairment of the CLP mice and markedly decreased the level of Nogo-B in the hippocampus tissues. The efficacy of CB2R activation to promote microglia polarization from M1 to M2 was diminished in BV2 cells overexpressing Nogo-B, although its anti-inflammatory effect was not entirely reversed. Inhibiting the Nogo-B expression, which in turn encourages the conversion of BV2 microglia to M2, attenuates inflammatory responses, and promotes neuronal repair, could be a key mechanism whereby activation of CB2R ameliorates septic encephalopathy.
Keywords: CB2R; Microglia; Nogo-B; Sepsis-associated encephalopathy.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: All experimental procedures were conducted at Wuhan University and approved by the Wuhan University Center for Animal Experiment/ABSL-III Laboratory (IACUC NO.: SQ20200094). Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
Similar articles
-
Administration of 2-deoxy-D-glucose alleviates cancer-induced bone pain by suppressing microglial polarization to the M1 phenotype and neuroinflammation.Mol Pain. 2025 Jan-Dec;21:17448069251348778. doi: 10.1177/17448069251348778. Epub 2025 May 30. Mol Pain. 2025. PMID: 40444883 Free PMC article.
-
Irisin ameliorates cognitive impairment in a lipopolysaccharide-induced neuroinflammation mouse model by inhibiting the NLRP3 inflammasome pathway in microglia.Neuropharmacology. 2025 Nov 1;278:110572. doi: 10.1016/j.neuropharm.2025.110572. Epub 2025 Jun 23. Neuropharmacology. 2025. PMID: 40562230
-
Hydroxysafflor yellow A attenuates the inflammatory response in cerebral ischemia-reperfusion injured mice by regulating microglia polarization per SIRT1-mediated HMGB1/NF-κB signaling pathway.Int Immunopharmacol. 2025 Feb 6;147:114040. doi: 10.1016/j.intimp.2025.114040. Epub 2025 Jan 10. Int Immunopharmacol. 2025. PMID: 39798476
-
Microglial activation as a hallmark of neuroinflammation in Alzheimer's disease.Metab Brain Dis. 2025 May 17;40(5):207. doi: 10.1007/s11011-025-01631-9. Metab Brain Dis. 2025. PMID: 40381069 Review.
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
References
-
- Cecconi M, Evans L, Levy M, Rhodes A (2018) Sepsis and septic shock. Lancet 392(10141):75–87. https://doi.org/10.1016/S0140-6736(18)30696-2 - DOI - PubMed
-
- van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG (2017) The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 17(7):407–420. https://doi.org/10.1038/nri.2017.36 - DOI - PubMed
-
- Zhang YY, Ning BT (2021) Signaling pathways and intervention therapies in sepsis. Signal Transduct Target Ther 6(1):407. https://doi.org/10.1038/s41392-021-00816-9 - DOI - PubMed - PMC
-
- Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T (2009) Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 37(10 Suppl):S331–S336. https://doi.org/10.1097/CCM.0b013e3181b6ed58 - DOI - PubMed
-
- Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, Dal-Pizzol F (2005) Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33(1):221–223, 262–263. https://doi.org/10.1097/01.ccm.0000150741.12906.bd
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous